Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis
about
Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis
description
clinical trial
@en
klinisch onderzoek
@nl
name
Single-Center Study Evaluating ...... ubjects With Actinic Keratosis
@en
type
label
Single-Center Study Evaluating ...... ubjects With Actinic Keratosis
@en
prefLabel
Single-Center Study Evaluating ...... ubjects With Actinic Keratosis
@en
P1050
P1476
A Phase 1 Open-label, Uncontro ...... ubjects With Actinic Keratosis
@en
P3098
NCT03575780
P580
2018-09-07T00:00:00Z
P582
2019-04-01T00:00:00Z